Cite
Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept.
MLA
Demacker, P. N., et al. “Chylomicron Processing in Familial Dysbetalipoproteinemia and Familial Combined Hyperlipidemia Studied with Vitamin A and E as Markers: A New Physiological Concept.” Atherosclerosis, vol. 149, no. 1, Mar. 2000, pp. 169–80. EBSCOhost, https://doi.org/10.1016/s0021-9150(99)00326-3.
APA
Demacker, P. N., Hectors, M. P., & Stalenhoef, A. F. (2000). Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept. Atherosclerosis, 149(1), 169–180. https://doi.org/10.1016/s0021-9150(99)00326-3
Chicago
Demacker, P N, M P Hectors, and A F Stalenhoef. 2000. “Chylomicron Processing in Familial Dysbetalipoproteinemia and Familial Combined Hyperlipidemia Studied with Vitamin A and E as Markers: A New Physiological Concept.” Atherosclerosis 149 (1): 169–80. doi:10.1016/s0021-9150(99)00326-3.